Skip navigation
FACT
Focus on Alternative and Complementary Therapies

CAM in allergies – determinants of use

Bockelbrink A1, Ring J2, Wichmann HE3, Schäfer T4
1Institute of Medical Statistics and Epidemiology Technical University Munich, Ismaningerstr. 22, Munich, 81675, Germany
2Department of Dermatology and Allergy Technical University Munich, am Biederstein, Munich, Germany
3Institute of Epidemiology and Institute of Medical Data Processing, Biometrics and Epidemiology, GSF National Research Centre for Environment and Health, Ludwig-Maximilians-University Munich, Munich, Germany
4Department of Social Medicine, Medical University Lübeck, Lübeck, Germany

Objective

The aim of this study was to identify determinants of use of CAM for allergies and to assess psychosocial characteristics of German adults with allergies who do or do not use CAM.

Materials and methods

In a population-based nested case-control study, computer-assisted telephone interviews were performed in 351 subjects with allergies (hay fever, asthma, atopic eczema and food hypersensitivity). Information on demographics, prevalence, motivation, CAM type and provider, costs, subjective assessment of complementary and conventional treatment and health-related quality of life (QoL) was obtained.

Results

A total of 26.5% of participants used CAM [homoeopathy (35.3%), autologous blood injection (28.1%), acupuncture (16.6%), bioresonance (10.0%)] for their allergies. Users were significantly younger (age median 43 vs. 47) and better educated (school education > 8 years vs. ≤8 years: OR 2.17) than non-users and mostly motivated by the assumption of few side-effects (78.3%), the wish to try everything (71.7%) and unsatisfying results of conventional therapy (66.3%). CAM was predominantly provided by medical doctors (60.9%) and associated with overall costs of median 205 €. Users felt a greater impact on health-related QoL and scored the efficacy of conventional therapy significantly lower than non-users. The majority of users assessed the results of CAM as very or rather good (82.4%).

Conclusion

CAM is widely used for allergies in the general population and is associated with considerable costs. Users and non-users of CAM with allergies can be distinguished regarding their views on medical treatment and health-related QoL.

Acknowledgement

This study was exclusively funded by the German Ministry of Education, Science, Research, and Technology (Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie, 01EG9703/7).

Top | Next: Integration vs. collaboration: what is the goal?»
© Pharmaceutical Press 2007
Accessibility | Terms and Conditions